Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cost of Revenue | Cost of Revenue Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 0 | 0% | $ 476K |
3/31/2025 | $ 0 | 0% | $ 605K |
12/31/2024 | $ 0 | 0% | $ 501K |
9/30/2024 | $ 0 | 0% | $ 493K |
6/30/2024 | $ 0 | 0% | $ 486K |
3/31/2024 | $ 0 | 0% | $ 423K |
12/31/2023 | $ 0 | 0% | $ 424K |
9/30/2023 | $ 0 | 0% | $ 354K |
6/30/2023 | $ 0 | 0% | $ 407K |
3/31/2023 | $ 0 | 0% | $ 398K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
COGS / Revenues
(=) COGS %
COGS % for VYNE THERAPEUTICS INC is calculated as follows: COGS [ $ 858K ] / Revenues [ $ 16.71M ]
(=) COGS % [ 5.14% ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2022
Average
Median
filtered constituents | 3.8K |
---|---|
min | -50.26% |
max | 172.25% |
average | 46.87% |
median | 50.52% |
std | 31.57% |